Upgrade to SI Premium - Free Trial

Abbvie (ABBV) PT Raised to $212 at Goldman Sachs

February 3, 2025 5:17 AM
Goldman Sachs analyst Chris Shibutani raised the price target on Abbvie (NYSE: ABBV) to $212.00 (from $208.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles